Using BCG vaccination to protect against COVID-19: when reality fails to meet expectation
LF Pittet, CCA Noble, NL Messina… - Nature Reviews …, 2024 - nature.com
While anticipating the development of a COVID-19-specific vaccine, several randomized
controlled trials (RCTs) explored the potential of BCG vaccination to protect against COVID …
controlled trials (RCTs) explored the potential of BCG vaccination to protect against COVID …
Exploring BCG vaccination as a novel approach to prevent recurrent herpes labialis
W Gong, J Du, L Zhuang, X Wu - EClinicalMedicine, 2023 - thelancet.com
According to WHO, approximately 3.7 billion individuals under the age of 50 years (67%)
carry herpes simplex virus type 1 (HSV-1), the primary cause of herpes labialis. 1 Although …
carry herpes simplex virus type 1 (HSV-1), the primary cause of herpes labialis. 1 Although …
[HTML][HTML] Hypothesis: BCG vaccination as a treatment option for ME/CFS and Long COVID
H Renz-Polster - patientresearchcovid19.com
Abstract The Bacillus Calmette-Guérin (BCG) vaccine has notable “trained immunity” effects.
It has shown therapeutic effects in autoimmune diseases such as type 1 diabetes (T1D) and …
It has shown therapeutic effects in autoimmune diseases such as type 1 diabetes (T1D) and …